OpenLB
Open Library of Bioscience
Advanced Search
P & T : a peer-reviewed journal for formulary management
Jul, 2018;43 (7): 396-399.

Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.

Jena Patel, Mary Barna Bridgeman
Author Information
PMID: 30013296

Abstract

Etelcalcetide (Parsabiv) for hyperparathyroidism in adults with chronic kidney disease on hemodialysis.

References

  1. CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):484-94 [PMID: 27639083]
  2. JAMA. 2017 Jan 10;317(2):146-155 [PMID: 28097355]
  3. JAMA. 2017 Jan 10;317(2):156-164 [PMID: 28097356]
  4. Kidney Int Rep. 2017 Feb 20;2(4):634-644 [PMID: 29142982]
  5. Fed Regist. 2015 Nov 6;80(215):68967-9077 [PMID: 26552112]
  6. Kidney Int Suppl (2011). 2017 Dec;7(3):e1 [PMID: 30681074]
Journal Article

Word Cloud

Created with Highcharts 10.0.0EtelcalcetideParsabivhyperparathyroidismadultschronickidneydiseasehemodialysisSecondaryHyperparathyroidismAdultsChronicKidneyDiseaseHemodialysis

Similar Articles

Cited By